Boardroom Alpha
Meeting calendar
AGNT · Annual meeting · Friday, April 24, 2026

Agnt Inc

6 nominees · 4 ballot items.

Election of six directors; Ratification of Deloitte & Touche LLP as independent auditor for 2026; Non-binding advisory vote to approve 2025 executive compensation (Say-on-Pay); Approval of redomestication from Delaware to Texas by conversion.

Market cap
$753M
1Y TSR
-51.1%
Board grade
D
Record date
Feb 27, 2026
Filing
DEF 14A
Meeting concluded · Apr 24, 2026

Follow how the vote landed and what changed on Agnt Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of six director nominees (Glenn Sanford, Randall Miles, Dan Cahir, Monica Weakley, Peggie Pelosi, Fred Reichheld) to serve until the next annual meeting.

  2. 2

    Ratification of Appointment of Independent Auditor for 2026

    ManagementBoard: FOR

    Ratify appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026.

  3. 3

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the named executive officers for 2025 as disclosed in the proxy statement.

    More detail

    The proposal is a routine annual advisory "say-on-pay" vote where shareholders are asked to approve, on a non-binding basis, the 2025 compensation of the Company’s named executive officers as disclosed in the proxy statement. Management seeks affirmation that its compensation philosophy, including base salary, discretionary cash bonuses (changed for 2026), and long-term equity incentives, aligns with stockholder interests and results. The Compensation Committee reviews outcomes and considers the vote when setting future pay. The board recommends FOR because it believes the program attracts and retains leadership, aligns pay with performance, promotes retention, and reflects market practices; the vote does not bind the board but informs future compensation decisions.

  4. 4

    Approval of Redomestication from Delaware to Texas, by Conversion

    ManagementBoard: FOR

    Approve conversion of eXp World Holdings, Inc. from a Delaware corporation to a Texas corporation (redomestication) by adopting the Plan of Conversion, Texas Certificate of Formation (Texas Charter), and Texas Bylaws.

    More detail

    This is a transaction-level management proposal seeking stockholder approval to redomesticate the company from Delaware to Texas by statutory conversion. The Board formed a Special Independent Committee of two disinterested directors due to derivative litigation against several directors; that Committee evaluated alternatives and recommended Texas because of recent Texas corporate law changes offering procedural protections (e.g., 3% derivative ownership threshold, codified business judgment rule protections, exclusive Texas business court forum) and potential cost savings including Delaware franchise tax elimination, lower risks from opportunistic litigation, and closer alignment with the company’s substantial Texas operations. The proposal asks shareholders for two separate affirmative votes (statutory majority of outstanding shares and a majority of votes cast by disinterested stockholders) because the conversion affects internal affairs and director/officer protections. The Board recommends FOR, noting the conversion won’t change the company’s operations, management, or stock rights, and that outstanding securities and awards will convert on a one-for-one basis. Potential downsides include loss of Delaware precedent, uncertainties with a newer Texas business court, venue changes, modified appraisal and inspection rights, and the possibility of litigation; the Company disclosed these and engaged Delaware and Texas counsel. The proposal includes adoption of Texas charter and bylaws and a plan of conversion; if approved the conversion would become effective upon filing of required documents. The Committee and Board believe the governance and litigation-procedural benefits outweigh the risks and recommend stockholders approve the redomestication.

Director elections

Nominees on the ballot6

Independent
Tenure on this board
7.6 yrs
Independent
Tenure on this board
3.5 yrs
Also a director at
Usana Health Sciences Inc (USNA)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.6.1%9,964,136$60M
2VANGUARD PORTFOLIO MANAGEMENT LLC5.4%8,924,311$53M
3VANGUARD CAPITAL MANAGEMENT LLC2.6%4,211,985$25M
4STATE STREET CORP2.0%3,334,034$20M
5RENAISSANCE TECHNOLOGIES LLC1.6%2,682,816$16M
6BlackRock, Inc.1.5%2,522,425$15M
7GEODE CAPITAL MANAGEMENT, LLC1.3%2,201,385$13M
8CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.3%2,067,151$12M
9GOLDMAN SACHS GROUP INC0.8%1,335,408$8M
10Invesco Ltd.0.7%1,131,298$7M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Agnt Inc 2026 annual meeting?
Agnt Inc (AGNT) holds its 2026 annual shareholder meeting on Friday, April 24, 2026.
What is the record date for the Agnt Inc 2026 meeting?
The record date for the Agnt Inc 2026 meeting is Friday, February 27, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Agnt Inc's 2026 meeting?
The board is presenting 6 director nominees at the Agnt Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Agnt Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Agnt Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer